Oculis Holding AG (OCS) EBIT (2022 - 2026)
Oculis Holding AG (OCS) posted EBIT of $392,224 for Q2 2026, up 24.4% from $315,259 a year earlier and up 47.0% from the prior quarter.
Powered by 
Analysis
Oculis Holding AG (OCS) EBIT (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Oculis Holding AG was $1.48 million, up 66.9% year-over-year; for FY2025, it came in at $1.5 million, up 92.4% from FY2024.
- Annual EBIT shows a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- In prior years, Oculis Holding AG's EBIT was $779,777 in FY2024 (-21.7%), $995,454 in FY2023 (+4.1%), $956,035 in FY2022 (-9.0%) and $1.05 million in FY2021 (-0.8%).
- Quarterly EBIT has run from a low of $3,425 in Q4 2024 to a high of $514,231 in Q4 2025 over five years.
- On a year-over-year basis, EBIT increased in five of the last seven quarters, with an average decline of 3.8%.
- The strongest year-over-year quarter for EBIT in the past five years was Q1 2025, with growth of 24.6%; the weakest was Q4 2024, with a decline of 98.4%.
- According to Business Quant data, EBIT for the three prior quarters was $266,894 (Q1 2026), $514,231 (Q4 2025) and $303,777 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Oculis Holding AG | 473.32 Mn | 473.32 Mn | - | 392,224.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392,224.12 |
| Mar 31, 2026 | 266,893.98 |
| Dec 31, 2025 | 514,230.78 |
| Sep 30, 2025 | 303,776.61 |
| Jun 30, 2025 | 315,259.35 |
| Mar 31, 2025 | 316,991.40 |
| Dec 31, 2024 | 3,424.57 |
| Sep 30, 2024 | 249,308.76 |
| Jun 30, 2024 | 270,919.40 |
| Mar 31, 2024 | 254,341.47 |
| Dec 31, 2023 | 208,560.58 |
| Sep 30, 2023 | 247,941.41 |
| Jun 30, 2023 | 278,043.89 |
| Mar 31, 2023 | 247,586.23 |
| Dec 31, 2022 | 222,136.69 |
| Sep 30, 2022 | 209,162.24 |
| Jun 30, 2022 | 265,803.01 |
API Access
Oculis Holding AG EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=OCS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();